Viewing nowPitastojung 2 Milligrams (Pitavastatin Calcium Hydrate)
Pitavastatin Calcium Hydrate 2mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

MFDS item code 201907500 · Approved 2019.10.28 · Insurance code 647304300
Improves hypercholesterolemia and dyslipidemia
This medication is used as an adjunct to dietary therapy for patients with primary hypercholesterolemia and mixed dyslipidemia. It helps improve blood lipid status by reducing total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels while increasing HDL-cholesterol levels. This, in turn, contributes to reducing the risk of cardiovascular diseases. It is essential for patients to take this medication consistently while maintaining a healthy diet and exercise. This medication effectively improves abnormalities in blood lipids.
For adults, the usual initial dose of pitavastatin calcium is 1 to 2 milligrams, taken once daily. If the LDL-cholesterol-lowering effect is insufficient, the dose may be increased up to a maximum of 4 milligrams per day. The dosage may be adjusted at intervals of 4 weeks or more according to LDL-cholesterol levels, treatment goals, and patient response.
This medication is used for the treatment of hypercholesterolemia and should not be administered to certain patients. Patients who have had allergic reactions to this medication's ingredients or those with active liver disease or severe liver dysfunction should not take it. Additionally, it should not be given to patients taking cyclosporine, patients with myopathy, pregnant women, women who may become pregnant, breastfeeding women, and children. Patients with reduced kidney function or a history of liver dysfunction, those who overconsume alcohol, and the elderly should use this medication with caution. This medication may cause various side effects, including myalgia, muscle weakness, liver function abnormality, and allergic reactions, so it is essential to consult a doctor immediately if any unusual symptoms occur. In particular, if myalgia or weakness, or changes in urine color appear, it may signify a serious side effect called rhabdomyolysis, and administration should be discontinued immediately. This medication is primarily metabolized in the liver, so regular liver function tests should be conducted, and if liver enzyme levels rise, administration should be terminated. Additionally, blood lipid levels should be regularly monitored to evaluate treatment effectiveness, and if there is no effectiveness, reconsideration of the medication's use may be necessary. There are many interactions with other medications, so caution is necessary, especially when taken with cyclosporine, fibrates, niacin, and erythromycin, as the risk of muscle-related side effects may increase with these combinations. The elderly have a higher risk of side effects due to reduced body function, so dose adjustment and caution are necessary. Pregnant and breastfeeding women should not take this medication due to the risks to the fetus and newborn, and medication should be discontinued immediately if pregnancy is confirmed. Finally, the safety and efficacy of this medication in children have not been established, so it is a principle not to use it in the pediatric population. This medication should be stored in its original container, safely away from children’s reach.
Hives, severe swelling (edema), severe edema accompanied by elevated blood pressure, chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions, severe rash accompanied by high fever, blisters, severe skin reactions such as skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities associated with cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden
Abdominal pain, rash, fatigue, itching, numbness, dry mouth, dyspepsia, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastrointestinal discomfort, diarrhea, stiffness, drowsiness, insomnia, headache, dizziness, skin tingling, increased blood pressure, chest discomfort, weakness, palpitations, fatigue, skin pain, burning sensation, joint pain, swelling, blurred vision, photophobia, hearing loss, hematuria, increased uric acid levels, elevated serum potassium and phosphorus levels, mild
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in an opaque container that does not allow light to enter. It is essential to maintain a storage temperature between 1 and 30 degrees Celsius (room temperature) to preserve its efficacy longer.
Very light yellowish-red round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPitavastatin Calcium Hydrate 2mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

Pitavastatin Calcium Hydrate 1mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Pitavastatin Calcium Hydrate 2mg
Tablet · Prescription medication
JW Pharmaceutical Corporation
Pitavastatin Calcium 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.